IPO Offerings | Form Type |
1st Lead Manager
Listed |
Initial Filing Date | Offer Date |
---|---|---|---|---|
Big Rock Partners Acquisition Corp. | 424B4 | EarlyBirdCapital, Inc. | 10/13/17 | 11/20/17 |
Initial IPO Filings | Form Type | 1st Lead Manager
Listed |
Initial Filing Date | |
---|---|---|---|---|
Industrial Logistics Properties Trust | S-11 | UBS Securities LLC | 11/21/17 |
IPO Withdrawals | Form Type | 1st Lead Manager
Listed |
Initial Filing Date | Withdrawal Date |
---|---|---|---|---|
Highland Acquisition Corporation | RW | Ladenburg Thalmann & Co. Inc. | 5/23/16 | 11/20/17 |
Use IPO Vital Sign #336 to…
Stitch Fix made its public market debut recently at $15 per share, $3 below the bottom of its published price range of $18 to $20 per share. The price cut was widely attributed to lower demand due to the relatively poor performance of high-profile technology IPOs like Blue Apron and Snap. However, a closer look at November’s deals shows that pricing weakness spread beyond just high-tech deals.
By November’s midpoint, six of the month’s 19 completed offerings had priced below the minimum filing price range, with each of those six issuers representing a different industry. November’s total is double the number of deals that priced below their stated range in each of September and October. Prior to November, May had seen the greatest IPO pricing instability with seven out of 21 new issues selling below the initial range.
Recent pricing difficulties are an exception in 2017, which so far has seen the lowest level of IPOs priced below the minimum filing price in a decade. Even with the recent increase, only 23% of deals completed between January 1st and November 15th had to sell below the intended range. That compares to 29.9% in 2016 and 33.5% in 2015. The closest any recent year has come to 2017’s 23% is 2009 when 25% of offerings priced below the minimum filed range. In the last decade, 2012 saw the largest percentage with 39% of that year’s 141 new issues priced below the minimum filing price.
The 2017 IPO company that slashed its offer price the most is YogaWorks. The company filed a price range of $12 to $14, but priced at $5.50 per share, a 57.7% drop from the midpoint of the initial range. Three other new issuers have priced 50% or more below the midpoint of the filing range. Immuron reduced its price by 52.4%, Calyxt by 51.5% and Elevate Credit by 50%.
The bulk of 2017’s new issues (just over 60%) have priced within the filing range. The year is on pace to exceed both 2015 and 2016, which finished with 53.8% and 43.2%, respectively, of IPOs priced within the filling range. Through November 15th, 14.8% of 2017’s IPOs have priced above the range, which is better than 2016’s 12.8% but lags behind 2015’s 20.5%.
Final IPO Pricing
v.
Initial
Filing Range
2015 Through November 2017*
(* Data through November 15, 2017)
IPO
Vital Signs Subscribers see,
#446. Final Pricing v. Initial
Filing Price Range.
First Day Movement - In
general, IPOs completed between January 1st and
November 15th started off well, with 93 new
issues gaining at least 1% in value on their first trading
day. Seven of the year’s IPO companies saw their shares remain
flat on initial trading day, while the shares of 33 issuers lost
value on the first day.
The top first-day gainer in 2017 is
Newater Technology, whose shares jumped 78.6%
on their first trading day. Rhythm Pharmaceuticals
posted the second largest gain by climbing 76.5% from $17 to $30
on its initial trading day. At +72.4%, CarGurus
enjoyed the third largest first-day gain of the year so far. In
all, nine issuers saw their shares rise 50% or more on their
first day.
Companies whose shares dropped in value on the initial trading day have not fared too badly, with only 12 falling 10% or more. The largest first-day loss was a 41.4% drop by Funko on November 1st. Allena Pharmaceuticals’ shares dropped 28.7% on their initial trading day, while shares of Aileron Therapeutics fell 28%.
2017 Top Ten IPO First Day Pricing
Gains
(IPOs First Trading from 1/1/17 to 11/20/17*)
(* Data through November 20, 2017)
IPO
Vital Signs Subscribers see,
#290. IPO First Day Pricing
Statistics.
Post First-Day Performance - Since its impressive first-day gain, Newater Technology has continued to climb, posting a 98.2% gain through November 21st. The year’s top performing IPO through that date is AnaptysBio, whose shares have risen 428.2%. Seven other companies’ shares have more than doubled in value, led by SMART Global Holdings (+232.1%) and UroGen Pharma (+214.7%). Overall, 84 companies that have made their market debuts this year have increased at least 1% in value since they began trading.
Despite getting off to the second fastest start of the year, shares of Rhythm Pharmaceuticals have slid backwards in subsequent trading. After a 76.5% first-day gain, Rhythm’s shares traded 64.1% above the IPO price as of November 21st. On the other side of the spectrum is G1 Therapeutics, whose shares finished their first day (May 17th) with no gain, but as of November 21st had risen 35% above their debut price.
Of the industries that have produced at least
five IPO companies in 2017, pharmaceutical preparations (SIC
2834) has turned in the best aftermarket performance as a group.
The sector is up 31.5% as a whole so far this year. Although
some software companies have struggled, as a group prepackaged
software (SIC 7372) shares are up 29.6% as of November 21st.
(Ranked by Initial Filing Date)
The IPO Line-Up contains IPO Registrants that have had filing activity in the last 8 weeks
and have not gone public or withdrawn from registration.
IPO Registrants that are red and bold indicate that a filing with the initial IPO price range has been filed with the SEC.
IPO Registrant | Form Type | 1st Lead Mgr Listed | Initial Filing Date | Filing w/ Initial Price Range | 10/2 - 10/6 | 10/9 - 10/13 | 10/16 - 10/20 | 10/23 - 10/27 | 10/30 - 11/3 | 11/6 - 11/10 | 11/13 - 11/17 | 11/20 - 11/24 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Industrial Logistics Properties Trust | S-11 | UBS | 11/21/17 | -- | -- | -- | -- | -- | -- | -- | -- | S-11 |
Casa Systems, Inc. | S-1 | Morgan Stanley | 11/17/17 | -- | -- | -- | -- | -- | -- | -- | S-1 | -- |
Advantage Insurance Inc. | S-1 | Raymond James | 11/16/17 | -- | -- | -- | -- | -- | -- | -- | S-1 | -- |
GigCapital, Inc. | S-1 | Cowen | 11/15/17 | 11/15/17 | -- | -- | -- | -- | -- | -- | S-1 | -- |
Hudson Ltd. | F-1 | Credit Suisse | 11/14/17 | -- | -- | -- | -- | -- | -- | -- | F-1 | -- |
FARMMI, Inc. | F-1 | ViewTrade | 11/14/17 | -- | -- | -- | -- | -- | -- | -- | F-1 | -- |
Camposol Holding Plc | F-1 | BofA Merrill Lynch | 11/14/17 | -- | -- | -- | -- | -- | -- | -- | F-1 | -- |
Americold Realty Trust | S-11 | BofA Merrill Lynch | 11/14/17 | -- | -- | -- | -- | -- | -- | -- | S-11 | -- |
TFI TAB Gida Yatirimlari A.S. | F-1 | Morgan Stanley | 11/13/17 | -- | -- | -- | -- | -- | -- | -- | F-1 | -- |
Odonate Therapeutics, LLC | S-1 | Goldman Sachs | 11/13/17 | -- | -- | -- | -- | -- | -- | -- | S-1 | -- |
LexinFintech Holdings Ltd. | F-1 | Goldman Sachs | 11/13/17 | -- | -- | -- | -- | -- | -- | -- | F-1 | 11/20 |
Denali Therapeutics Inc. | S-1 | Goldman Sachs | 11/13/07 | -- | -- | -- | -- | -- | -- | -- | S-1 | -- |
AXA Equitable Holdings, Inc. | S-1 | Morgan Stanley | 11/13/17 | -- | -- | -- | -- | -- | -- | -- | S-1 | -- |
Quanterix Corporation | S-1 | JPMorgan | 11/9/17 | -- | -- | -- | -- | -- | -- | S-1 | -- | -- |
Luther Burbank Corporation | S-1 | Keefe Bruyette | 11/9/17 | -- | -- | -- | -- | -- | -- | S-1 | -- | -- |
Entera Bio Ltd. | F-1 | Oppenheimer | 11/9/17 | -- | -- | -- | -- | -- | -- | F-1 | -- | 11/20 |
Leisure Acquisition Corp. | S-1 | Morgan Stanley | 11/3/17 | 11/3/17 | -- | -- | -- | -- | S-1 | -- | 11/16 | 11/24 |
Senmiao Technology Limited | S-1 | ViewTrade | 10/30/17 | -- | -- | -- | -- | -- | S-1 | -- | -- | 11/22 |
Insurance Income Strategies Ltd. | S-1 | Joseph Gunnar | 10/24/17 | -- | -- | -- | -- | S-1;10/27 | -- | -- | -- | -- |
Newmark Group, Inc. | S-1 | Goldman Sachs | 10/23/17 | -- | -- | -- | -- | S-1 | -- | -- | -- | 11/20 |
CURO Group Holdings Corp. | S-1 | Credit Suisse | 10/23/17 | -- | -- | -- | -- | S-1 | 11/1 | 11/6 | -- | -- |
iClick Interactive Asia Group Limited | F-1 | Network 1 | 10/20/17 | -- | -- | -- | F-1 | -- | -- | -- | -- | 11/22 |
WatchGuard, Inc. | S-1 | Barclays | 10/19/17 | -- | -- | -- | S-1 | -- | -- | -- | -- | -- |
Workspace Property Trust | S-11 | Goldman Sachs | 10/13/17 | 10/31/17 | -- | S-11 | 10/19 | 10/27 | 10/31;11/3 | 11/9 | -- | -- |
One Madison Corporation | S-1 | Credit Suisse | 10/13/17 | 10/13/17 | -- | S-1 | -- | -- | -- | -- | -- | -- |
Regalwood Global Energy Ltd. | S-1 | Citigroup | 10/2/17 | 10/2/17 | S-1 | -- | -- | -- | 11/3 | -- | 11/16 | 11/24 |
Howard Midstream Partners, LP | S-1 | Barclays | 9/12/17 | -- | -- | -- | 10/18 | -- | -- | -- | -- | 11/21 |
Molino Canuelas S.A.C.I.F.I.A. | F-1 | JPMorgan | 9/8/17 | 11/6/17 | -- | -- | 10/19 | -- | -- | 11/6 | -- | -- |
Hancock Jaffe Laboratories, Inc. | S-1 | WallachBeth | 9/7/17 | 11/6/17 | -- | -- | -- | -- | -- | 11/6 | -- | -- |
Adial Pharmaceuticals, Inc. | S-1 | Joseph Gunnar | 9/6/17 | 9/6/17 | -- | -- | -- | 10/25 | -- | -- | -- | 11/22 |
ReTo Eco-Solutions, Inc. | F-1 | ViewTrade | 8/4/17 | 8/4/17 | -- | 10/13 | -- | -- | -- | -- | 11/13 | -- |
ProLung, Inc. | S-1 | Maxim Group | 8/4/17 | 10/17/17 | -- | -- | 10/17 | -- | -- | -- | -- | -- |
LiveXLive Media, Inc. | S-1 | BMO | 5/11/17 | 10/6/17 | 10/6 | -- | 10/16 | -- | -- | -- | -- | -- |
Nine Energy Service, Inc. | S-1 | JPMorgan | 5/2/17 | -- | -- | -- | -- | -- | -- | -- | 11/13 | -- |
Vine Resources Inc. | S-1 | Credit Suisse | 4/10/17 | -- | -- | -- | -- | -- | -- | -- | -- | 11/21 |
Liberty Oilfield Services Inc. | S-1 | Morgan Stanley | 2/14/17 | -- | -- | -- | -- | -- | -- | 11/9 | -- | -- |
FTS International, Inc. | S-1 | Credit Suisse | 2/10/17 | -- | -- | -- | -- | -- | 10/30 | -- | -- | -- |
Albertsons Companies, Inc. | S-1 | Goldman Sachs | 7/8/15 | -- | -- | -- | -- | -- | -- | 11/8 | -- | -- |
IPO Line-Up includes all IPO registrants that have filed to go public in the U.S., have neither gone public nor formally withdrawn their offering by filing a Form RW with the SEC, and have had filing activity in the most recent eight week period. IPO Line-Up includes all SEC registered IPOs, including REITs and those non-U.S. IPO filers seeking to list in the U.S. markets, except for 1) closed-end funds; 2) best-efforts, self-underwritten, and direct offerings; and 3) small business IPOs with an offering amount of less than $5 million. IPO Line-Up: Recent SEC IPO Filing Activity is based on information provided from the IPO Vital Signs System located at https://www.ipovitalsigns.com/